Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-22-046254
Filing Date
2022-08-17
Accepted
2022-08-17 16:22:04
Documents
1
Period of Report
2022-08-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 6877
  Complete submission text file 0001209191-22-046254.txt   8241
Mailing Address ONE SANSOME STREET SUITE 3630 SAN FRANCISCO CA 94104
Business Address
LINK WILLIAM J PHD (Reporting) CIK: 0001228684 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39614 | Film No.: 221174346

Mailing Address 15440 LAGUNA CANYON ROAD IRVINE CA 92618
Business Address 15440 LAGUNA CANYON ROAD IRVINE CA 92618 (949) 409-9820
Tarsus Pharmaceuticals, Inc. (Issuer) CIK: 0001819790 (see all company filings)

EIN.: 814717861 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)